Work

C1-07: IPI-504, a novel HSP90 inhibitor is effective in EGFR T790M and Non-T790M Gefitinib-resistant Lung Cancer Cell Lines.

Year: 2007

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1097/01.jto.0000283194.48953.03

Authors: Joon Oh Park, Feng Zhao, Kreshnik Zejnullahu, Emmanuel Normant, Jeffrey A. Engelman, Bruce E. Johnson, Pasi A. Jänne

Institutions: Dana-Farber Cancer Institute, Infinity Pharmaceuticals (United States), Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2030076116

FWCI:

Cites:

Cited by: 1

Related to: 10